241 related articles for article (PubMed ID: 25343831)
1. Cardiac and renal fibrosis in chronic cardiorenal syndromes.
Hundae A; McCullough PA
Nephron Clin Pract; 2014; 127(1-4):106-12. PubMed ID: 25343831
[TBL] [Abstract][Full Text] [Related]
2. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
3. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
Halade GV; Kain V; Ingle KA
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal Syndrome Revisited.
Zannad F; Rossignol P
Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
[TBL] [Abstract][Full Text] [Related]
5. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction.
Westermann D; Lindner D; Kasner M; Zietsch C; Savvatis K; Escher F; von Schlippenbach J; Skurk C; Steendijk P; Riad A; Poller W; Schultheiss HP; Tschöpe C
Circ Heart Fail; 2011 Jan; 4(1):44-52. PubMed ID: 21075869
[TBL] [Abstract][Full Text] [Related]
6. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
7. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Cardiorenal-like Syndrome in Aged Chimpanzees (Pan troglodytes).
Chilton J; Wilcox A; Lammey M; Meyer D
Vet Pathol; 2016 Mar; 53(2):417-24. PubMed ID: 26792841
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells.
Schreier B; Rabe S; Schneider B; Ruhs S; Grossmann C; Hauptmann S; Blessing M; Neumann J; Gekle M
Hypertens Res; 2011 May; 34(5):623-9. PubMed ID: 21346767
[TBL] [Abstract][Full Text] [Related]
13. HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy.
Yamamoto M; Hanatani S; Araki S; Izumiya Y; Yamada T; Nakanishi N; Ishida T; Yamamura S; Kimura Y; Arima Y; Nakamura T; Takashio S; Yamamoto E; Sakamoto K; Kaikita K; Matsushita K; Morimoto S; Ito T; Tsujita K
J Am Heart Assoc; 2021 Aug; 10(15):e021069. PubMed ID: 34320813
[TBL] [Abstract][Full Text] [Related]
14. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
15. Mechanical control of cardiac myofibroblasts.
van Putten S; Shafieyan Y; Hinz B
J Mol Cell Cardiol; 2016 Apr; 93():133-42. PubMed ID: 26620422
[TBL] [Abstract][Full Text] [Related]
16. Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.
Terker AS; Sasaki K; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Nwosisi S; Zhang MZ; Harris RC
Am J Physiol Renal Physiol; 2021 Apr; 320(4):F569-F577. PubMed ID: 33522414
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved.
Delgado-Valero B; Cachofeiro V; Martínez-Martínez E
Cells; 2021 Jul; 10(7):. PubMed ID: 34359993
[TBL] [Abstract][Full Text] [Related]
18. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
19. Action of SNAIL1 in Cardiac Myofibroblasts Is Important for Cardiac Fibrosis following Hypoxic Injury.
Biswas H; Longmore GD
PLoS One; 2016; 11(10):e0162636. PubMed ID: 27706205
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes.
Virzì GM; Clementi A; Brocca A; Ronco C
Blood Purif; 2017; 44(4):314-326. PubMed ID: 29161706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
